40 results
424B5
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
Prospectus supplement for primary offering
7:00am
initial purchase commitment as indicated in the table above.
No Sales of Similar Securities
We, our executive officers, directors and certain of our … rights, if any;
whether there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether shareholders
424B5
PROK
ProKidney Corp - Ordinary Shares
10 Jun 24
Prospectus supplement for primary offering
5:13pm
commitment as indicated in the table above.
No Sales of Similar Securities
We, our executive officers, directors and certain of our shareholders have … backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether shareholders are entitled to oversubscription rights
8-K
EX-10.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
to Bruce Culleton, Chief Executive Officer (“Supervisor”).
Duties and Commitment:
You shall be employed by the Company on a full-time basis and shall
424B5
PROK
ProKidney Corp - Ordinary Shares
19 Jan 24
Prospectus supplement for primary offering
4:16pm
backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether shareholders are entitled to oversubscription rights
8-K/A
EX-10.1
7fhar824m3kk
5 Dec 23
Departure of Directors or Certain Officers
4:06pm
S-3
sbp5q29
22 Nov 23
Shelf registration
9:22am
424B3
auxvy0dyc bp8qn8g
21 Apr 23
Prospectus supplement
4:18pm
POS AM
14s3ejhkp3u0 6sa
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
stspwrs
9 Sep 22
Prospectus supplement
5:05pm
8-K
EX-10.4
2syb6t2kf9uhoyepl
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
8-K
EX-10.11
pax gy8m4y
15 Jul 22
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq
5:24pm
DEFM14A
x53bfhz2 s75kdk
10 Jun 22
Proxy related to merger
4:54pm